Yousif Capital Management LLC Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Yousif Capital Management LLC cut its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 53,020 shares of the medical equipment provider’s stock after selling 789 shares during the period. Yousif Capital Management LLC’s holdings in Intuitive Surgical were worth $27,674,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter valued at approximately $38,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $579.65 on Wednesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market capitalization of $206.46 billion, a P/E ratio of 90.43, a P/E/G ratio of 5.51 and a beta of 1.39. The business has a 50 day moving average price of $551.24 and a 200 day moving average price of $511.16.

Insider Buying and Selling

In other news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 in the last ninety days. Insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research reports. Raymond James upped their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Royal Bank of Canada upped their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, Jefferies Financial Group increased their price objective on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.